跳至主要内容
临床试验/JPRN-UMIN000031459
JPRN-UMIN000031459已完成2 期

Phase II study of safety and efficacy of alternating R-CHOP and R-HDMA therapy in high-risk diffuse large B-cell lymphoma - Safety and efficacy of alternating R-CHOP and R-HDMA therapy in high-risk DLBC

Division of Hematology, Keio University School of Medicine0 个研究点目标入组 5 人开始时间: 2018年3月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1 Involvement of central nervous system 2 HBs antigen positive 3 HCV antibody positive 4 HIV antibody positive 5 Active synchronous malignancy 6 Patients who are pregnant, lactating, or possibly pregnant 7 Patients who receive steroid therapy for other diseases 8 Patients with uncontrolled infection 9 Severe allergy to drugs used in this study 10Patients who the researcher judged inappropriate as the subject

研究者

发起方
Division of Hematology, Keio University School of Medicine

相似试验